Search results
Found 6 matches for
Recently, Professor Chris Butler addressed the United Nations regarding the PANORAMIC Trial and the assistance of BAPS UK & Europe.
PANORAMIC hits the 20,000 participant milestone
General Recruitment
31 March 2022
The world’s largest study of community-based treatments for acute COVID-19 has reached a world-first, historic milestone: over twenty thousand participants from across the UK have now taken part in the PANORAMIC trial.
Largest Hindu temple in Europe helps to spread awareness of the PANORAMIC study
General Recruitment
11 March 2022
Europe’s BAPS Swaminarayan Sanstha, the largest Hindu temple outside of India, is supporting their community during the coronavirus pandemic by spreading awareness of the PANORAMIC trial of COVID-19 treatments.
Covid 19: Anti-viral drug study open to patients in NI
General Recruitment Research
8 March 2022
New Story from the BBC: People in Northern Ireland are being urged to take part in a study which will help decide how antiviral drugs will be used to treat Covid-19.
University of Bolton student champions praised for support in University of Oxford Covid-19 treatment trials
General New medications Recruitment
24 February 2022
Student Champions from the University of Bolton who have helped to recruit volunteers through community outreach work for the world’s largest trials to treat Covid-19 have been congratulated for their hard work.
BBC: Patients wanted for Oxford and Southampton Unis' take-at-home pill trial
General Recruitment Research
14 February 2022
Researchers studying the use of an antiviral drug people can take at home to treat Covid want thousands more volunteers to join their trial. Scientists at Oxford and Southampton Universities are looking at how molnupiravir can reduce symptoms in people at risk of serious illness. They have signed up 8,000 recently diagnosed with the virus but want thousands more to join the trial.
Recruitment begins for national community COVID-19 antiviral trial
General Recruitment Research
8 December 2021
Researchers from the University of Oxford have today started recruiting participants for a first-of-its-kind clinical trial to test novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 and those who are at higher risk of complications – partnering with the National Institute for Health Research (NIHR) and working with colleagues in several UK universities, and the NHS UK-wide.